Adherence to Antihypertensive Treatment and Associated Factors in Central Ethiopia

الملخص EN

Background.

Adherence to treatment is a primary determinant of treatment success.

Nonadherence attenuates clinical benefits to the recipients of the treatment.

However, monitoring adherence to long treatment regimens is not given due emphasis in low-income contexts.

This study aimed to assess adherence to antihypertensive treatment and factors associated with it in Central Ethiopia.

Method.

This is an institution-based cross-sectional study conducted in 4 public hospitals in Central Ethiopia from December 4, 2016, to September 25, 2017.

The Morisky Medication Adherence Scale (MMAS-8) was used to assess the level of adherence.

The Revised Illness Perception Questionnaire (IPQ-R) was used to assess illness perception.

The MMAS-8 score ranges from 0 to 8, a score of 8 reflects high adherence, 6 to 7 medium adherence, and <6 low adherence.

Results.

A total of 989 hypertensive patients participated in the study, of which 36.0% were assessed to have high adherence, 31.7% medium adherence, and 32.3% low adherence.

We found that treatment adherence was significantly and positively associated with having family support (AOR: 1.65; 95% CI = 1.23, 2.22), high perception about consequences of hypertension (AOR: 1.51; 95% CI = 1.17, 1.95), and high perception about the severity of the disease (AOR: 1.42; 95% CI = 1.09, 1.86).

Conclusion.

The treatment adherence to antihypertensive medications is low in Central Ethiopia.

Engaging family members in the treatment plan and improving patients’ understanding of the illness are critical in achieving high adherence to medication in this context.